Abstracts from 2014 through the most recent CROI can be viewed in this searchable database once they have been presented at the conference. Abstract Contents: The searchable database includes abstract text as submitted by the authors prior to CROI. Study data might be updated during the presentation at CROI. Please refer to the electronic poster or webcast for updates. Searching the Abstract Database: Enter the criteria below and click the “Search” button. After the search has been entered, the results will appear below the search form.
CROI conference materials (eg, the conference program, Abstract eBook, electronic posters, CROI logo, etc) are protected by copyright. Permission to replicate or reproduce these elements, in whole or in part, must be obtained from the CROI Conference Manager, the International Antiviral Society-USA (IAS-USA). Study data (including figures within abstracts or electronic posters) are the property of the study authors. Permission to use data and figures cannot be given by IAS–USA unless it is for regulatory reasons. For more information, please email CROIabstracts@iasusa.org.
1277 Results
Background PrEP adherence and persistence are suboptimal in real-world settings, with half to two thirds of PrEP users discontinuing within 6 months. We describe results of a comparative effectiveness trial of two mobile health technologies to support PrEP use among MSM and transgender people in the US. Methods HIV-uninfected MSM and trans people were enrolled…
Background Poor retention in HIV care has been associated with adverse clinical outcomes. We sought to understand barriers to care and factors related to being out of care (OOC) in the DC Cohort, a longitudinal cohort of PWH in Washington, DC, using data from clinical care sites and linked data from the DC Department of…
Background In 2020, approximately 50% of newly diagnosed persons living with HIV (PLHIV) had a baseline CD4 <200 cells/µL in Thailand. As a result, the Ministry of Public Health implemented and expanded the national index partner testing (IPT) program to increase early HIV detection (baseline CD4 ≥200 cells/µL) and rapid antiretroviral (ART) treatment initiation. We…
Background Self-harm and suicidal ideation are significant health concerns among people with or vulnerable to HIV (PWH), who frequently experience stigma and related mental health challenges such as stress, anxiety, and depression. The AI-powered MARVIN chatbot provides HIV self-management-related knowledge and assists with medication adherence (antiretroviral therapy and pre-exposure prophylaxis). It also provides a safe…
Background Providing pregnant and lactating people (PLP) with choice in PrEP methods, including long-acting injectable cabotegravir (CAB-LA), may mitigate barriers to PrEP continuation. We evaluated PrEP preferences and acceptability of their chosen method among PLP offered CAB-LA versus oral PrEP in South Africa. Methods The PrEPared to Choose study in Cape Town, South Africa, enrolled…
Background Viral load suppression (VLS) is crucial for controlling HIV transmission and improving health outcomes in people living with HIV. While PEPFAR-supported programs have made substantial progress in improving VLS, innovative approaches are needed to sustain and enhance VLS in resource-limited settings. This analysis integrates machine learning and the difference-in-difference (DiD) method to forecast future…
Background The transition to integrase inhibitors has been associated with weight gain and increases in cardiometabolic risk factors, but evidence for the impact of this transition over longer time horizons in populations with HIV-negative comparators is limited. We evaluated the impact of the switch from efavirenz to dolutegravir (DTG) on weight and a suite of…
Background Digital health interventions are a promising approach for increasing access to health information and services, but low or non-sustained engagement can limit effectiveness. We examined how exposure to and engagement with a digital family planning and reproductive health (FP/RH) intervention (“CyberRwanda”) influenced the intervention’s impact for Rwandan adolescents. Methods A 3-arm, cluster randomized, hybrid…
Background The anticipated approval of lenacapavir for HIV pre-exposure prophylaxis (PrEP) may present an opportunity to better address inequitable PrEP implementation among priority populations in the United States (US). We examined potential preferences for long-acting PrEP methods among transgender and gender-diverse (TGD) adults in the US. Methods From April to June 2022, we conducted an…
Background Despite increasing pre-exposure prophylaxis (PrEP) utilization, access to providers offering PrEP services remains limited and unevenly distributed across the US. This study leveraged a novel linkage of commercial and public datasets to examine socioeconomic and geographic disparities in PrEP provider availability. Methods Providers who prescribed ≥1 PrEP regimen from 2021 to 2023 were identified…